Branded generics occupies 90% of the Rs 1-lakh cr pharma market in India
The authority maintained that it was witnessing a large number of non-compliance cases every month
NPPA has till date recovered only 7.8 per cent of fines related to overpricing; dues run in to Rs 3,698.32 crore